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Introduction: Approximately 16% of acutely ill older adults develop new, long-term cognitive impairment 
(LTCI), many of whom initially seek care in the emergency department (ED). Currently, no effective 
interventions exist to prevent LTCI after an acute illness. Identifying early and modifiable risk factors 
for LTCI is the first step toward effective therapy. We hypothesized that Vitamin D deficiency at ED 
presentation was associated with LTCI in older adults. 
Methods: This was an observational analysis of a prospective cohort study that enrolled ED patients ≥ 
65 years old who were admitted to the hospital for an acute illness. All patients were enrolled within four 
hours of ED presentation. Serum Vitamin D was measured at enrollment and Vitamin D deficiency was 
defined as serum concentrations <20 mg/dL. We measured pre-illness and six-month cognition using the 
short form Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE), which ranges from 1 to 
5 (severe cognitive impairment). Multiple linear regression was performed to determine whether Vitamin 
D deficiency was associated with poorer six-month cognition adjusted for pre-illness IQCODE and other 
confounders. We incorporated a two-factor interaction into the regression model to determine whether the 
relationship between Vitamin D deficiency and six-month cognition was modified by pre-illness cognition. 
Results: We included a total of 134 older ED patients; the median (interquartile range [IQR]) age was 74 
(69, 81) years old, 61 (46%) were female, and 14 (10%) were nonwhite race. The median (IQR) vitamin 
D level at enrollment was 25 (18, 33) milligrams per deciliter and 41 (31%) of enrolled patients met criteria 
for vitamin D deficiency. Seventy-seven patients survived and had a six-month IQCODE. In patients 
with intact pre-illness cognition (IQCODE of 3.13), Vitamin D deficiency was significantly associated with 
worsening six-month cognition (β-coefficient: 0.43, 95% CI, 0.07 to 0.78, p = 0.02) after adjusting for pre-
illness IQCODE and other confounders. Among patients with pre-illness dementia (IQCODE of 4.31), no 
association with Vitamin D deficiency was observed (β-coefficient: -0.1;, 95% CI, [-0.50-0.27], p = 0.56).
Conclusion: Vitamin D deficiency was associated with poorer six-month cognition in acutely ill older 
adult ED patients who were cognitively intact at baseline. Future studies should determine whether early 
Vitamin D repletion in the ED improves cognitive outcomes in acutely ill older patients. [West J Emerg 
Med. 2019;20(6)XX-XX.] 
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INTRODUCTION
Long-term cognitive impairment (LTCI), defined as 
new or worsening deficit in cognition that persists following 
acute illness, is a well described phenomenon occurring in 
an estimated 16% of older adults who are acutely ill.1 This 
often leads to increased disability, loss of independence, and 
decreased quality of life. Currently no effective therapies, 
especially those that can be administered early in the acute 
illness course, exist to prevent or treat LTCI following acute 
illness. 
While the mechanism of LTCI has not been fully 
elucidated, it is hypothesized that systemic proinflammatory 
cytokines, in response to an acute medical illness such as 
sepsis,2 lead to increased central nervous system (CNS) 
inflammation, microglial activation, and neuronal injury and 
death.2 Vitamin D is a pleotropic hormone that modulates 
systemic and CNS inflammatory responses.3 Therefore, 
patients with Vitamin D deficiency may be particularly 
vulnerable to LTCI following an acute illness. Several 
observational studies have suggested that Vitamin D 
deficiency is associated with poorer long-term cognition 
among community-dwelling adults.4 However, the 
relationship between Vitamin D deficiency in the setting of 
acute illness and subsequent development of LTCI remains 
unknown in acutely ill patients, especially in the emergency 
department (ED) setting. Therefore, we sought to determine 
whether serum Vitamin D at ED presentation was associated 
with poorer six-month cognition in acutely ill older adults. 
METHODS
This study was an observational secondary analysis 
within the DELINEATE prospective cohort study, which 
enrolled ED patients age 65 years and older who were 
subsequently admitted the hospital for an acute illness at a 
large, academic, tertiary care hospital.5 This study enrolled 
patients from March 2012 – November 2014. The local 
institutional review board reviewed and approved this study. 
Details and rationale of the selection of participants have 
been described previously.5 Briefly, we included patients 
if they were 65 years or older and in the ED for less than 
four hours at the time of enrollment. Patients were excluded 
if they were non-English speaking; previously enrolled; 
deaf, comatose, non-verbal or unable to follow simple 
commands prior to their current illness; were considered 
unsuitable for enrollment by the treating physician or nurse; 
were unavailable for enrollment within the four-hour time 
limit secondary to clinical care (eg, procedures, radiologic 
testing, etc,); or were discharged home from the ED. Patients 
were included for this analysis if they had blood specimen 
available for Vitamin D measurement and had a surrogate 
available to complete a short form Informant Questionnaire 
on Cognitive Decline in the Elderly (IQCODE) obtained at 
enrollment to establish pre-illness cognition.
Pre-illness (baseline) and six-month cognition (primary 
outcome) were measured using the short form IQCODE in 
patients who had a surrogate in the ED who knew the patient 
for greater than 10 years. It ranges from 1 to 5 (severe 
cognitive impairment). This surrogate-based cognitive screen 
was used because patient-based measurements in the ED 
may not accurately reflect true baseline cognition especially 
in the setting of delirium.6 The IQCODE is also a validated 
measure of cognition, which has been previously used to 
assess cognitive decline5,7 At time of study enrollment, 
informants were asked to assess the patients’ pre-illness 
cognition at two weeks prior to ED presentation, and follow-
up assessment at six months over telephone with all attempts 
made to have the same person complete the IQCODE 
questionnaire as the individual who completed the pre-illness 
questionnaire. 
The primary independent variable was serum Vitamin D 
measured at ED enrollment. We used Vitamin D level at ED 
presentation to identify patients with pre-existing Vitamin 
D deficiency prior to hospitalization for an acute illness. 
Vitamin D deficiency was defined as a serum Vitamin D 
concentration <20 milligrams per deciliter (mg/dL).2 We 
collected blood in citrate anti-coagulated collection tubes 
immediately upon study enrollment. Tubes were placed on 
ice and centrifuged at 3000 g-force within one hour to isolate 
plasma. Samples were stored at -80C until batched Vitamin 
D measurements were performed using the Abbott Architect 
i2000 (Abbott Pharmaceuticals, Lake Bluff, IL). 
We used the Charlson comorbidity index to quantify 
patient comorbid burden.8 The Acute Physiology Score 
(APS) of the Acute Physiology and Chronic Health 
Evaluation II (APACHE II) score, including age, was used 
to quantify severity of illness.9 The presence of a CNS 
diagnosis (meningitis, seizure, cerebrovascular accident, 
transient ischemic attack, intraparenchymal hemorrhage, 
epidural hematoma, subdural hematoma, subarachnoid 
hemorrhage, cerebral edema, meningitis, etc,) was 
determined by two physician reviewers via medical record 
review. Any disagreement was adjudicated by a third 
physician reviewer. 
Statistical Analysis
To determine whether Vitamin D was associated with 
poorer six-month cognition, we performed multiple linear 
regression with Vitamin D deficiency as a binary variable 
adjusting for covariates, IQCODE, the Charlson comorbidity 
index, APS, and presence of a CNS diagnosis, which were 
all defined a priori. Because we previously observed that 
pre-existing cognition may modify any associations and 
long-term cognition,10 we incorporated a cross product of 
Vitamin D and pre-illness IQCODE in the linear regression 
model. If the interaction p-value was < 0.25, then it was 
retained in the multiple regression model. Because the 
IQCODE is a continuous variable, vitamin D’s b-coefficients 
are reported at the 25th and 75th percentile values of the 
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pre-illness IQCODE to represent those who were cognitively 
intact and cognitively impaired at baseline, respectively. 
Another multivariable model was run where serum Vitamin 
D deficiency was the independent variable. We used SAS 
version 9.4 (SAS Institute, Cary, NC) for statistical analysis. 
 
RESULTS
Of the 228 patients enrolled in the DELINEATE cohort, 
30 patients did not have a surrogate present to complete the 
pre-illness IQCODE and 64 did not have blood collected at 
enrollment leaving 134 participants available for this analysis. 
The patient characteristics stratified by Vitamin D deficiency 
status can be seen in the Table. The median (interquartile 
range) Vitamin D level at enrollment was 25 (18,33) mg/dL 
and 41 (31%) patients met criteria for Vitamin D deficiency.11 
Of the 134 patients, 25 (18.7%) died prior to the six-
month follow-up, four (3.0%) opted out of the follow-up 
at enrollment, 10 (7.5%) were lost to follow-up, and 18 
(13.4%) were successfully followed-up but a surrogate was 
not readily available to complete the six-month IQCODE. A 
total of 77 patients survived and had a six-month IQCODE. 
The interaction term between Vitamin D deficiency and pre-
illness IQCODE interaction’s p-value was significant (p = 
0.0111) indicating that the relationship between Vitamin D 
deficiency and six-month IQCODE was modified by the pre-
illness IQCODE. The Figure displays the multivariable linear 
regression models between serum Vitamin D at ED enrollment 
and adjusted six-month cognition. Among patients with a pre-
illness IQCODE of 3.13 (cognitively intact at baseline), for 
every 1 mg/dL decrease in serum Vitamin D, the six-month 
IQCODE score significantly increased by 0.18 points (95%CI: 
0.00 to 0.031) after adjusting for pre-illness IQCODE and 
other potential confounders; this indicated that lower serum 
Vitamin D concentrations measured at ED enrollment was 
associated with poorer six-month cognition. Among those 
with an IQCODE of 4.313 (cognitively impaired at baseline), 
no association with Vitamin D deficiency was observed 
(β-coefficient: 0.00; 95% CI, -0.01 to 0.02). Similarly, Vitamin 
D deficiency was significantly associated with worsening 
six-month cognition (adjusted β-coefficient: 0.44; 95% CI, 
0.09 to 0.79) among older adults cognitively intact at baseline 
(pre-illness IQCODE = 3.13). No association with Vitamin 
D deficiency was seen (β-coefficient: -0.10, 95% CI, -0.49 
to 0.29) in those with pre-illness cognitive impairment (pre-
illness IQCODE = 4.313). 
DISCUSSION
Our findings suggest that Vitamin D deficiency is 
common among older patients presenting to the ED with an 
acute medical illness, and Vitamin D deficiency is associated 
with increased risk for LTCI among older adults who are 
Non-Vitamin D Deficient* Vitamin D Deficient*
Median age (IQR) 74 (69, 82) 72 (67, 79)
Female gender 51 (54.8%) 22 (53.7%)
Non-white race 6 (6.5%) 8 (19.5%)
Median pre-illness IQCODE (IQR) 3.56 (3.06, 4.13) 3.19 (3.00, 4.00)
Median OARS ADL (IQR) 22 (15, 27) 25 (17, 27)
Median Charlson Comorbidity Index (IQR) 4 (3, 6) 4 (2, 5)
Median APS (IQR) 13 (12, 15) 15 (13, 18)
CNS diagnosis 20 (21.5%) 3 (7.3%)
ED chief complaint
Abdominal pain 4 (4.4%) 4 (10.3%)
Altered mental status 16 (17.4%) 7 (18.0%)
Chest pain 6 (6.5%) 5 (12.8%)
Generalized weakness 9 (9.8%) 2 (5.1%)
Nausea/vomiting 5 (5.4%) 0 (0.0%)
Shortness of breath 10 (10.9%) 5 (12.8%)
Syncope 4 (4.4%) 0 (0.0%)
IQR, Interquartile range; APS, Acute Physiology Score; IQCODE, Informant Questionnaire on Cognitive Decline in the Elderly score; 
OARS ADL, Older American Services Activities of Daily Living; CNS, central nervous system. 
The APS also incorporates age from the Acute Physiology and Chronic Health Evaluation II (APACHE II). 
*Vitamin D deficiency was defined as a serum concentration of less than 20 ng/dL.
Table 1. Patient characteristics and demographics.
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cognitively intact prior to an acute illness. Unfortunately, no 
intervention exists to preserve long-term cognition after an 
acute illness. The first step toward discovering an intervention 
is to identify modifiable risk factors early on in the course of 
an acute illness, and this is the impetus for our study. Future 
studies should determine if early Vitamin D repletion in the 
ED improves cognitive outcomes in acutely ill older patients.
We also observed that the association between serum 
Vitamin D concentrations and six-month cognition was more 
prominent in patients with intact cognition at baseline. It is 
possible that Vitamin D deficiency in the setting of acute 
illness may more profoundly affect those with intact cognition. 
It is also possible that patients with intact cognition at baseline 
are more at risk for cognitive decline following acute illness 
that is detectable with the measures currently available to 
assess cognition. Future studies should confirm this finding 
using more robust neuropsychiatric evaluations to quantify 
long-term cognition.
Our study builds upon the work conducted in the 
outpatient settings, which also reported that low- serum 
Vitamin D level is associated with the development 
of Alzheimer’s disease.4 Because systemic and CNS 
Figure. The relationship between serum Vitamin D concentrations measured at enrollment and 6-month cognition. Cognition was determined 
by the short Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) which ranged from 1 to 5 (severe cognitive impairment). 
The association between serum Vitamin D and 6-month cognition was modified by pre-illness cognition. In older adults with pre-illness 
cognitive impairment (higher IQCODE group, shown in RED), serum Vitamin D concentrations were not a predictor of adjusted 6-month 
cognition. In older adults who were cognitively intact at baseline (lower pre-illness IQCODE group, shown in BLUE), there was a statistically 
significant relationship between serum vitamin D concentrations and 6-month cognition after adjusting for confounders.
inflammation are the underpinning of LTCI pathophysiology, 
we hypothesize that Vitamin D treatment could potentially 
improve long-term cognition by attenuating systemic and CNS 
inflammatory responses. Vitamin D is a pleiotropic secosteroid 
hormone that modulates systemic and CNS inflammatory 
responses.12 Inflammation in response to an acute illness plays 
a prominent role in LTCI pathogenesis.13 Vitamin D down-
regulates systemic inflammation by inhibiting the release 
of peripheral pro-inflammatory cytokines such as tumor 
necrosis factor-α (TNF-α), IL-6 and IL-12.14,15 Additionally, 
Vitamin D also inhibits CNS inflammation by attenuating 
systemic inflammation and more directly by specifically 
targeting the brain. Based upon in-vitro models, Vitamin D 
further attenuates CNS inflammation by inhibiting microglial 
production of pro-inflammatory cytokines such as IL-6 and 
TNF-α.14 
LIMITATIONS
Our study has several limitations. First, the study was 
observational and thus was only able to assess association, 
not causation, between Vitamin D deficiency and long-term 
cognitive impairment. We used IQCODE to measure pre-
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illness and six-month cognition. While it has been previously 
used to characterize cognitive decline, it is possible that 
misclassification could have occurred and may have biased 
our findings.
Second, selection bias may have been introduced 
by enrolling patients from a single site and only during 
weekdays and daytime hours. Our primary analysis was 
based on 57% of enrolled patients due to death during 
the study period or no six-month IQCODE available for 
analysis. Patients with missing six-month IQCODEs were 
similar in age, pre-illness OARS ADL, comorbidity burden, 
severity of illness, proportion with altered mental status as 
a chief complaint, and the proportion with CNS diagnosis 
compared those with accessible six-month IQCODEs 
(Supplemental Table). However, patients with missing six-
month IQCODEs were more likely to be female, non-white 
race, and cognitively intact at baseline. 
Furthermore, our study was limited to a single, 
academic ,tertiary care hospital; thus, our findings may not 
be generalizable to other settings. Inherent to observational 
studies and limited by our sample size, unmeasured and 
residual confounding may exist. 
CONCLUSION
In older adults without pre-existing cognitive impairment 
(eg, dementia), Vitamin D deficiency at ED presentation was 
a risk factor for poorer six-month cognition. This relationship 
was present after adjusting for confounders chosen a 
priori such as other comorbidities, severity of illness, and 
the presence of pre-existing cognitive impairment and other 
CNS diagnoses. We found no such association with Vitamin 
D and LTCI among older adults with pre-illness cognitive 
impairment. This suggests that vitamin D deficiency among 
cognitively intact older adults at the time of ED presentation 
may be a potentially modifiable risk factor in the development 
of long-term cognitive impairment.
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